137 related articles for article (PubMed ID: 10355972)
1. An autopsy case of hepatoid carcinoma of the ovary with PIVKA-II production: immunohistochemical study and literature review.
Senzaki H; Kiyozuka Y; Mizuoka H; Yamamoto D; Ueda S; Izumi H; Tsubura A
Pathol Int; 1999 Feb; 49(2):164-9. PubMed ID: 10355972
[TBL] [Abstract][Full Text] [Related]
2. Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP).
Matsueda K; Yamamoto H; Yoshida Y; Notohara K
J Gastroenterol; 2006 Oct; 41(10):1011-9. PubMed ID: 17096071
[TBL] [Abstract][Full Text] [Related]
3. Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia.
Miskad UA; Yano Y; Nakaji M; Kishi S; Itoh H; Kim SR; Ku Y; Kuroda Y; Hayashi Y
Pathol Int; 2001 Dec; 51(12):916-22. PubMed ID: 11844063
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.
Nakagawa T; Seki T; Shiro T; Wakabayashi M; Imamura M; Itoh T; Tamai T; Nishimura A; Yamashiki N; Matsuzaki K; Sakaida N; Inoue K; Okamura A
Int J Oncol; 1999 Feb; 14(2):281-6. PubMed ID: 9917503
[TBL] [Abstract][Full Text] [Related]
5. Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Nasu M; Soma T; Fukushima H; Kudo K; Matsubara O
Mod Pathol; 1997 Oct; 10(10):1054-8. PubMed ID: 9346187
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
[TBL] [Abstract][Full Text] [Related]
7. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.
Caviglia GP; Ribaldone DG; Abate ML; Ciancio A; Pellicano R; Smedile A; Saracco GM
Scand J Gastroenterol; 2018 Jun; 53(6):734-740. PubMed ID: 29667463
[TBL] [Abstract][Full Text] [Related]
8. Protein induced by vitamin K absence or antagonist II (PIVKA-II) producing large cell neuroendocrine carcinoma (LCNEC) of lung with multiple liver metastases: A case report.
Kurohama H; Mihara Y; Izumi Y; Kamata M; Nagashima S; Komori A; Matsuoka Y; Ueki N; Nakashima M; Ito M
Pathol Int; 2017 Feb; 67(2):105-109. PubMed ID: 28075042
[TBL] [Abstract][Full Text] [Related]
9. Hepatoid carcinoma of the ovary and management.
Lazaro J; Rubio D; Repolles M; Capote L
Acta Obstet Gynecol Scand; 2007; 86(4):498-9. PubMed ID: 17486476
[TBL] [Abstract][Full Text] [Related]
10. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
Viggiani V; Palombi S; Gennarini G; D'Ettorre G; De Vito C; Angeloni A; Frati L; Anastasi E
Scand J Gastroenterol; 2016 Oct; 51(10):1257-62. PubMed ID: 27227515
[TBL] [Abstract][Full Text] [Related]
11. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein.
Suehiro T; Sugimachi K; Matsumata T; Itasaka H; Taketomi A; Maeda T
Cancer; 1994 May; 73(10):2464-71. PubMed ID: 7513601
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
[TBL] [Abstract][Full Text] [Related]
13. Hepatoid carcinoma of the ovary: immunohistochemical finding of one case and literature review.
Yiğit S; Uyaroğlu MA; Kuş Z; Ekinci N; Oztekin O
Int J Gynecol Cancer; 2006; 16(3):1439-41. PubMed ID: 16803543
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes.
Kasahara A; Hayashi N; Fusamoto H; Kawada Y; Imai Y; Yamamoto H; Hayashi E; Ogihara T; Kamada T
Dig Dis Sci; 1993 Dec; 38(12):2170-6. PubMed ID: 7505217
[TBL] [Abstract][Full Text] [Related]
15. Abnormal prothrombin: evaluation as a tumour marker and localization in tissues of patients with hepatocellular carcinoma.
Koda T; Yamazaki S; Tamura I; Nakaba H; Takao T; Katayama S; Kurimura O
J Gastroenterol Hepatol; 1993; 8(3):212-6. PubMed ID: 7686054
[TBL] [Abstract][Full Text] [Related]
16. Hepatoid carcinoma of the ovary--a case report.
Trivedi P; Dave K; Shah M; Karelia N; Patel D; Wadhwa M
Eur J Gynaecol Oncol; 1998; 19(2):167-9. PubMed ID: 9611059
[No Abstract] [Full Text] [Related]
17. Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma.
Park MS; Lee KW; Kim H; Choi YR; Hong G; Yi NJ; Suh KS
Transplant Proc; 2017 Jun; 49(5):1109-1113. PubMed ID: 28583537
[TBL] [Abstract][Full Text] [Related]
18. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Fujioka M; Nakashima Y; Nakashima O; Kojiro M
Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
[TBL] [Abstract][Full Text] [Related]
19. Hepatoid carcinoma of the ovary: a case report.
Matsuta M; Ishikura H; Murakami K; Kagabu T; Nishiya I
Int J Gynecol Pathol; 1991; 10(3):302-10. PubMed ID: 1717389
[TBL] [Abstract][Full Text] [Related]
20. [An alpha-fetoprotein and PIVKA-II producing carcinoma of the colon: report of a case].
Miyashita K; Nagasaka A; Nakanishi M; Kudo T; Wakahama O; Nishikawa S; Higuchi A; Sato H
Nihon Shokakibyo Gakkai Zasshi; 2000 Dec; 97(12):1480-6. PubMed ID: 11193493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
